http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7210029

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 524
issn 1557-8992
1044-5463
issueIdentifier 5
pageRange 517-524
publicationName Journal of Child and Adolescent Psychopharmacology
startingPage 517
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e423e98d115894f5b30465dcb1113e0c
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_94603c8d5d86d4ed898236c2313ee39b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_04bf18ca5eeba83a5f3bb5211cb7d221
bibliographicCitation Owley T, Salt J, Guter S, Grieve A, Walton L, Ayuyao N, Leventhal BL, Cook EH. AProspective, Open-Label Trial of Memantine in the Treatment of Cognitive, Behavioral, and Memory Dysfunction in Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 2006 Oct;16(5):517–24. doi: 10.1089/cap.2006.16.517.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_096414e663d5ed4b32dcb35c553cb659
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e17091ed96a29a5c5a880140e6bf93d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b5b6933b4cd41d70b934fcfa006bde1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45489481c805f750a78315e4fd1ddaa8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31e1dfd950ae5fcd7e6f79ab43bd4b4a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b5899d9e85c907cf89da390a109a796
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_077864a425b78c316dac55ef735ea20e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fab496cbc75c04f99290c5c5e18d376d
date 200610
identifier https://pubmed.ncbi.nlm.nih.gov/17069541
https://doi.org/10.1089/cap.2006.16.517
isPartOf https://portal.issn.org/resource/ISSN/1044-5463
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20630
https://portal.issn.org/resource/ISSN/1557-8992
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders
discusses http://id.nlm.nih.gov/mesh/M0028006
http://id.nlm.nih.gov/mesh/M0028010
http://id.nlm.nih.gov/mesh/M0013333
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008559Q000627
http://id.nlm.nih.gov/mesh/D018691Q000627
http://id.nlm.nih.gov/mesh/D002653Q000188
http://id.nlm.nih.gov/mesh/D008569Q000188
http://id.nlm.nih.gov/mesh/D002659Q000188
http://id.nlm.nih.gov/mesh/D003072Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D003072Q000175
http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D008569Q000523
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D009483
http://id.nlm.nih.gov/mesh/D002653Q000523
http://id.nlm.nih.gov/mesh/D003072Q000523
http://id.nlm.nih.gov/mesh/D002653Q000175
http://id.nlm.nih.gov/mesh/D002659Q000523
http://id.nlm.nih.gov/mesh/D008569Q000175
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D002659Q000175
http://id.nlm.nih.gov/mesh/D007805Q000523
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D018698Q000378
http://id.nlm.nih.gov/mesh/D007805Q000188
http://id.nlm.nih.gov/mesh/D002675
http://id.nlm.nih.gov/mesh/D007360Q000187
http://id.nlm.nih.gov/mesh/D007805Q000175
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID181458
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8077

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136088414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129583715

Total number of triples: 70.